Madelaine Feldman, MD: Practical Considerations for Biosimilars
Madelaine Feldman, MD, discusses practical concerns related to biosimilars, including physician confidence, formulary status, state-level interchangeability legislation, and the outlook for the marketplace.
March 15, 2019
View Text Version